Anebulo Pharmaceuticals, Inc. logo ANEB - Anebulo Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 3
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $6.00 DETAILS
HIGH: $6.00
LOW: $6.00
MEDIAN: $6.00
CONSENSUS: $6.00
UPSIDE: 1204.35%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 53.36
Quick Ratio 53.36
Solvency Ratio -17.398
Cash Ratio 51.87

Valuation Ratios

Ratio Value
Price/Earnings
-5.74
Peer avg not available.
PEG Ratio 0.26
Forward PEG 0.26
Price/Book 4.18
Price/Sales 0.00
Price/FCF -7.67
Price/Op Cash Flow -7.67

Debt Ratios

Ratio Value
Debt/Assets 0.0000
Debt/Equity 0.0000
Debt/Capital 0.0000
Long-Term Debt/Capital 0.0000
Financial Leverage 1.04

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -28.325
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -21.21
Interest Coverage -24.1444
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 0.00
Capital Expenditure Coverage -2116562.33
Dividend + Capital Expenditure Coverage -2116562.33

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -0.251
Debt/Share 0.0113
Cash/Share 0.34
Book Value/Share 0.34
Tangible BV/Share 0.34
Equity/Share 0.34
Operating Cash Flow/Share -0.188
Capital Expenditure/Share 0.000
FCF/Share -0.188

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.920
Price/Fair Value 4.18
Debt/Market Cap 0.0000
Effective Tax Rate 0.0%
Enterprise Value Multiple -4.58